Smoking cessation therapy Market (By Product: Nicotine Replacement Therapy [Gum, lozenges, Inhalers, Patches, Sprays], Drugs, Electronic Cigarettes, Others; By Sales Channel: Hospital Pharmacies, Online Channel, Retail Pharmacies, Other) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

CHAPTER 1. Industry Overview of Smoking Cessation Therapy
1.1. Definition and Scope
1.1.1. Definition of Smoking Cessation Therapy
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Smoking Cessation Therapy Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Smoking Cessation Therapy Market By Product
1.2.3. Smoking Cessation Therapy Market By Sales Channel
1.2.4. Smoking Cessation Therapy Market by Regions

CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Smoking Cessation Therapy Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Smoking Cessation Therapy Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2019
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2. R&D Status and Application Source of Smoking Cessation Therapy Major Manufacturers in 2019

CHAPTER 5. Smoking Cessation Therapy Market By Product
5.1. Introduction
5.2. Smoking Cessation Therapy Revenue By Product
5.2.1. Smoking Cessation Therapy Revenue (US$ Mn) and Forecast, By Product, 2016-2027
5.2.2. Nicotine Replacement Therapy
5.2.2.1. Nicotine Replacement Therapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.1. NRT Gum
5.2.2.1.1.1. NRT Gum Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.2. NRT lozenges
5.2.2.1.2.1. NRT lozenges Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.3. NRT Inhalers
5.2.2.1.3.1. NRT Inhalers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.4. NRT Patches
5.2.2.1.4.1. NRT Patches Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.5. Sprays
5.2.2.1.5.1. Sprays Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Drugs
5.2.3.1. Drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Electronic Cigarettes
5.2.4.1. Electronic Cigarettes Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Others
5.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 6. Smoking Cessation Therapy Market Revenue By Sales Channel
6.1. Introduction
6.2. Smoking Cessation Therapy Revenue (US$ Mn) By Sales Channel
6.2.1. Smoking Cessation Therapy Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
6.2.2. Hospital Pharmacies
6.2.2.1. Hospital Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Online Channel
6.2.3.1. Online Channel Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Retail Pharmacies
6.2.4.1. Retail Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Others
6.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 7. North America Smoking Cessation Therapy Market By Country
7.1. North America Smoking Cessation Therapy Overview
7.2. U.S.
7.2.1. U.S. Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
7.2.2. U.S. Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016-2027
7.3. Canada
7.3.1. Canada Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
7.3.2. Canada Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016-2027
7.4. North America PEST Analysis

CHAPTER 8. Europe Smoking Cessation Therapy Market By Country
8.1. Europe Smoking Cessation Therapy Market Overview
8.2. U.K.
8.2.1. U.K. Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.2.2. U.K. Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016-2027
8.3. Germany
8.3.1. Germany Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.3.2. Germany Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016-2027
8.4. France
8.4.1. France Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.4.2. France Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016-2027
8.5. Spain
8.5.1. Spain Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.5.2. Spain Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016-2027
8.6. Rest of Europe
8.6.1. Rest of Europe Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.6.2. Rest of Europe Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016-2027
8.7. Europe PEST Analysis

CHAPTER 9. Asia Pacific Smoking Cessation Therapy Market By Country
9.1. Asia Pacific Smoking Cessation Therapy Market Overview
9.2. China
9.2.1. China Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.2.2. China Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
9.3. Japan
9.3.1. Japan Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.3.2. Japan Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
9.4. India
9.4.1. India Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.4.2. India Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
9.5. Australia
9.5.1. Australia Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.5.2. Australia Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
9.6. South Korea
9.6.1. South Korea Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.6.2. South Korea Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.7.2. Rest of Asia-Pacific Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
9.8. Asia Pacific PEST Analysis

CHAPTER 10. Latin America Smoking Cessation Therapy Market By Country
10.1. Latin America Smoking Cessation Therapy Market Overview
10.2. Brazil
10.2.1. Brazil Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.2.2. Brazil Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
10.3. Mexico
10.3.1. Mexico Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.3.2. Mexico Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
10.4. Rest of Latin America
10.4.1. Rest of Latin America Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027

CHAPTER 11. Middle East & Africa Smoking Cessation Therapy Market By Country
11.1. Middle East & Africa Smoking Cessation Therapy Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.2.2. Saudi Arabia Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
11.3. UAE
11.3.1. UAE Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.3.2. UAE Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.4.2. Rest of Middle East & Africa Smoking Cessation Therapy Market Revenue (US$ Mn) and Forecast By Sales Channel, 2016 - 2027

CHAPTER 12. Player Analysis Of Smoking Cessation Therapy
12.1. Smoking Cessation Therapy Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Smoking Cessation Therapy Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 13. COMPANY PROFILE
13.1. Bayer AG (Germany)
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2019
13.1.3.2. Bayer AG (Germany) 2019 Smoking Cessation Therapy Business Regional Distribution
13.1.4. Product/ Service and Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. Manufacturing Plant Footprint Analysis
13.2. Cipla Ltd (India)
13.3. F. Hoffmann-La Roche AG (Switzerland)
13.4. GlaxoSmithKline plc (UK)
13.5. Imperial Tobacco Ltd. (UK)
13.6. Johnson and Johnson (US)
13.7. NJOY (US)
13.8. Novartis AG (Switzerland)
13.9. Pfizer, Inc. (US)
13.10. Reckitt Benckiser Plc (UK)
13.11. Revolymer plc
13.12. Takeda Pharmaceutical Company Ltd. (Japan)
13.13. VMR Products, LLC. (US)
13.14. Others


Cart Summary